Whales Ventures

Florida has emerged as a credible venture geography over the last several years, and Whales Ventures is among the smaller, more thesis-driven firms operating in that ecosystem. Based in Tampa, the firm writes pre-seed and seed checks into early-stage companies, with a published thematic focus that includes a Future of Healthcare pillar and a broader artificial intelligence orientation. Disclosed activity remains limited compared with larger coastal firms, which means founders engaging Whales should treat the relationship as a still-developing one rather than as an established institutional anchor.

The thesis at Whales Ventures organizes around a small set of pillars including healthcare, applied artificial intelligence, and other early-stage software categories. The firm’s healthcare interest sits squarely within digital health rather than spanning into biotech, devices, or clinical research, and the firm’s artificial intelligence focus suggests that healthcare bets are likely to skew toward AI-native companies rather than toward more traditional health IT. Founders pitching consumer wellness, fitness apps, or pure direct-to-consumer health products will find the firm’s mandate looser; founders pitching applied AI in clinical workflow, diagnostics support, or back-office healthcare automation will find a more focused conversation. The firm’s Florida geography means that founders with regional commercial wedges, particularly in Florida hospital systems or large physician groups, may find an additional sourcing angle that coastal firms cannot match.

Because the source data does not enumerate specific portfolio companies, founders should plan to source named references directly through the firm during diligence. The published material emphasizes thesis areas rather than a track record of named bets, which is consistent with the firm’s medium-confidence positioning in third-party data. Founders engaging Whales should expect a real conversation about thesis alignment but should also be prepared for a partner team that is still building visible portfolio momentum.

Check sizes are not publicly disclosed in a tight band, which is consistent with smaller emerging firms that adjust deployment to fit the round and the syndicate. The firm’s pre-seed and seed positioning suggests deployment capacity in the high-six-figure to low-seven-figure range, with selective participation rather than lead-anchored commitments. Founders looking for an institutional lead at seed should expect Whales to participate alongside a larger lead rather than to anchor; founders raising pre-seed rounds with multiple smaller checks may find Whales a natural co-investor.

Decision-making sits with a small Tampa-based team. The firm’s decision-making cadence has not been publicly characterized in detail, but small emerging firms generally move faster than larger institutional funds when they are interested and slower than larger funds when their attention is divided. Founders should ask explicitly about timing during initial conversations.

The most effective approach is a warm introduction through a Florida ecosystem operator or through a founder the firm has already engaged. Cold inbound is read but rarely prioritized at smaller emerging firms because partner attention is the binding constraint. Founders should be specific about their healthcare or AI angle and should be prepared to articulate why a Florida-based investor is a fit for their company in concrete terms.

Founders should know that Whales Ventures is an emerging firm with a defined thesis but limited disclosed activity. The firm is a credible secondary participant in a syndicate; it is not yet positioned to function as a lead institutional anchor for most healthcare founders. Founders raising rounds with multiple investors and looking for a thesis-aligned co-investor with regional Florida exposure may find Whales a useful addition; founders looking for a single institutional lead at seed should look elsewhere first and consider Whales as a participant rather than as an anchor.